Arrakis Therapeutics, Inc.

Biotechnology company · Waltham, Massachusetts, United States

Arrakis Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Arrakis Therapeutics at a glance

Typebiotechnology company

HeadquartersWaltham, Massachusetts, United States

Earliest incorporation on record2015

SEC CIK1699493

What does Arrakis Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $15 million sold (2019).

Frequently asked questions about Arrakis Therapeutics

Where is Arrakis Therapeutics headquartered?

Arrakis Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Arrakis Therapeutics do?

Arrakis Therapeutics, Inc. is a biotechnology company.

When was Arrakis Therapeutics founded?

The earliest incorporation on record for Arrakis Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Repligen CorpWaltham, Massachusetts, United States
TScan Therapeutics, Inc.Waltham, Massachusetts, United States
La Jolla Pharmaceutical CoWaltham, Massachusetts, United States
MINERVA BIOTECHNOLOGIES CorpWaltham, Massachusetts, United States
Dianthus Therapeutics, Inc.Waltham, Massachusetts, United States
Viridian Therapeutics, Inc.Waltham, Massachusetts, United States
Pyramid Biosciences, Inc.Waltham, Massachusetts, United States
Mythic Therapeutics, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences